Crouse Hospital
Syracuse, New York, 13210, United States
NCT Number: NCT01610622
Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.
Looking for future studies?
Notify MeUp to 1 month
All sexes
Observational
Syracuse, New York, 13210, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Isotonic saline, which is the indicator, is injected to obtain COstatus cardiac output measurements.
No other interventions are made for the purpose of the study.
Transonic Systems Inc.
Industry
Acronym: CH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06740344
Neonatal Intensive Care
Dublin, Leinster, Ireland
View Trial DetailsNCT07423962
Neonatal Care, Neonatal Intensive Care
Aydin, Efeler, Turkey (Türkiye)
View Trial DetailsNCT06488196
Neonatal Intensive Care
St. Petersburg, Florida, United States
View Trial DetailsNCT05806320
Female Urogenital Diseases and Pregnancy Complications, Neonatal Intensive Care
Istanbul, Turkey (Türkiye)
View Trial Details